
Medical experts are evaluating whether a single dose of the HPV vaccine can provide sufficient protection against human papillomavirus instead of the traditional two-dose regimen.
A recent study tracking over 20,000 girls in Costa Rica found that a single HPV shot offered approximately 97% protection against cervical cancer.
About 63% of US teenagers currently receive both recommended vaccine doses, with vaccination rates remaining flat for four consecutive years.